Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 to 72

Methadone to reduce long-term opioid use after major spine surgery

Official title: Methadone to Reduce Chronic Opioid Use After Major Spine Surgery: The MEND Pilot Feasibility Study

Run by The Cleveland Clinic · NCT07222072 · Data updated 2026-11-12

This pilot trial will test whether a short course of postoperative oral methadone can help adults having multilevel lumbar or thoracic spine fusion use fewer opioids three months after surgery.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 72 Years
SexAll
Enrollment120 (estimated)
SponsorThe Cleveland Clinic
Academic / other
Locations1 site (Cleveland, Ohio)
StatusRecruiting
StartedNovember 15, 2025
Main results expectedOctober 2027
Study endsOctober 2028
Registry record updatedDecember 17, 2025
Trial IDNCT07222072 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

English-speaking adults aged 18–72 scheduled for multilevel lumbar or thoracic spine fusion with BMI ≤40 who are not pregnant and have no known methadone allergy are ideal candidates.

Probably not a fit

Patients who are pregnant, have BMI >40, a known methadone allergy, or who do not speak English are excluded and may not receive benefit from this trial.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, triple-blinded, placebo-controlled pilot feasibility trial comparing postoperative oral methadone to placebo in patients undergoing multilevel lumbar or thoracic spine fusion. The trial will enroll adult English-speaking patients at a single center and collect data on feasibility, safety, and preliminary opioid use outcomes at three months. Investigators will use the pilot data to plan a larger definitive trial testing methadone's opioid-sparing effects after spine surgery. Standard exclusion criteria include extreme obesity (BMI >40), pregnancy, known methadone allergy, and non-English speakers.

Why it matters

Potential benefit: If successful, the approach could reduce the risk of prolonged opioid use and its harms after spine surgery.

How similar studies have gone: Short-term intraoperative or postoperative methadone has shown opioid-sparing effects in other surgical settings, but its effect on three-month opioid use after spine surgery has not been established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult ≥ 18 years of age
* Scheduled for multilevel lumbar and/or thoracic spine fusion (primary or revision)

Exclusion Criteria:

* \<18 or \>72 Years of age
* Body Mass Index \>40
* Known allergy to methadone
* Pregnant females
* Non-English-speaking patients

Where it's running

  • Cleveland Clinic
    Cleveland, Ohio, United States
    Recruiting

Study contacts

  • Principal investigator: Shobana Rajan, MD — The Cleveland Clinic
  • Study coordinator: Stephanie Stoianoff, MBA
  • Email: stoians@ccf.org
  • Phone: 12164440231

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.